SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKG.L Regulatory News (SKG)

  • There is currently no data for SKG

Form 38.5a (EPT/RI) - Amendment

9 May 2018 16:01

RNS Number : 5599N
Citigroup Global Markets Limited
09 May 2018
 

FORM 38.5(a) - Amendment

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

Amendment to section 2(a)

 

1. KEY INFORMATION

 

Name of exempt principal trader

Citigroup Global Markets Limited

Company dealt in

Smurfit Kappa Group plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

0.001 Ordinary Shares

Date of dealing

4 May 2018

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

372,243

EUR 35.0462

EUR 33.9600

1,290

GBP 30.6281

GBP 30.3885

 

 

 

 

 

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

264,316

EUR 35.1000

EUR 33.9600

1,116

GBP 30.6000

GBP 30.3189

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

TRS

Increasing Short Position

69,290

34.7676

TRS

Reducing Short Position

52

30.60

TRS

Reducing Short Position

20

30.56

TRS

Reducing Short Position

19

30.56

TRS

Reducing Short Position

28

30.48

TRS

Reducing Short Position

13,333

34.5161

TRS

Increasing Short Position

293

30.4518

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

Date of disclosure

9 May 2018

Contact name

 Damian Flanagan

Telephone number

00 44 (0)28 90409676

Name of offeree/offeror with which connected

Smurfit Kappa Group plc

Nature of connection (Note 6)

 Financial Advisor

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEUKVSRWKAVRAR
Date   Source Headline
29th Feb 20244:42 pmRNSTotal Voting Rights
26th Feb 20249:51 amRNSHolding(s) in Company
21st Feb 20245:16 pmRNSHolding(s) in Company
19th Feb 20249:35 amRNSBlock listing Interim Review
16th Feb 20245:05 pmRNSDirector/PDMR Shareholding
14th Feb 202412:08 pmRNSHolding(s) in Company
14th Feb 202411:08 amRNSHolding(s) in Company
13th Feb 202412:22 pmRNSHolding(s) in Company
6th Feb 20244:14 pmRNSHolding(s) in Company
6th Feb 202412:19 pmRNSHolding(s) in Company
2nd Feb 20245:13 pmRNSHolding(s) in Company
2nd Feb 202412:38 pmRNSHolding(s) in Company
1st Feb 20245:26 pmRNSHolding(s) in Company
30th Jan 20243:44 pmRNSHolding(s) in Company
30th Jan 20243:35 pmRNSHolding(s) in Company
11th Jan 20249:48 amRNSHolding(s) in Company
5th Jan 20244:42 pmRNSHolding(s) in Company
2nd Jan 20242:02 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20232:38 pmRNSHolding(s) in Company
19th Dec 20234:01 pmRNSHolding(s) in Company
14th Dec 202311:01 amRNSHolding(s) in Company
11th Dec 202311:17 amRNSHolding(s) in Company
8th Dec 20233:41 pmRNSHolding(s) in Company
7th Dec 202312:30 pmRNSHolding(s) in Company
6th Dec 20235:04 pmRNSHolding(s) in Company
6th Dec 202310:12 amRNSHolding(s) in Company
1st Dec 20234:11 pmRNSDirector/PDMR Shareholding
1st Dec 20232:34 pmRNSHolding(s) in Company
1st Dec 20239:59 amRNSHolding(s) in Company
28th Nov 20235:10 pmRNSHolding(s) in Company
27th Nov 202312:47 pmRNSHolding(s) in Company
24th Nov 202310:12 amRNSHolding(s) in Company
23rd Nov 20233:36 pmRNSHolding(s) in Company
22nd Nov 20235:28 pmRNSHolding(s) in Company
20th Nov 202312:41 pmRNSHolding(s) in Company
15th Nov 20233:50 pmRNSHolding(s) in Company
9th Nov 20234:20 pmRNSDirector/PDMR Shareholding
6th Nov 20239:50 amRNSHolding(s) in Company
3rd Nov 202310:27 amRNSHolding(s) in Company
1st Nov 20237:00 amBUSTrading Statement
31st Oct 202312:40 pmRNSHolding(s) in Company
30th Oct 20233:22 pmRNSHolding(s) in Company
27th Oct 20232:24 pmRNSHolding(s) in Company
26th Oct 202310:22 amRNSHolding(s) in Company
24th Oct 20235:25 pmRNSHolding(s) in Company
24th Oct 20239:32 amRNSHolding(s) in Company
23rd Oct 20231:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.